Detalles de la búsqueda
1.
Asenapine for the treatment of adults with an acute exacerbation of schizophrenia: results from a randomized, double-blind, fixed-dose, placebo-controlled trial with olanzapine as an active control.
CNS Spectr;
22(4): 333-341, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27821210
2.
Efficacy and tolerability of an mGlu2/3 agonist in the treatment of generalized anxiety disorder.
Neuropsychopharmacology;
33(7): 1603-10, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-17712352
3.
Randomized, Double-Blind, Placebo-Controlled Trial of Asenapine Maintenance Therapy in Adults With an Acute Manic or Mixed Episode Associated With Bipolar I Disorder.
Am J Psychiatry;
175(1): 71-79, 2018 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28946761
4.
Effects of asenapine on agitation and hostility in adults with acute manic or mixed episodes associated with bipolar I disorder.
Neuropsychiatr Dis Treat;
13: 2955-2963, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29270013
5.
Exploring the long-term safety of asenapine in adults with schizophrenia in a double-blind, fixed-dose, extension study.
Neuropsychiatr Dis Treat;
13: 2021-2035, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28814871
6.
Long-term safety and tolerability of asenapine: A double-blind, uncontrolled, long-term extension trial in adults with an acute manic or mixed episode associated with bipolar I disorder.
J Affect Disord;
207: 384-392, 2017 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27755982
7.
Long-term Safety of Asenapine in Pediatric Patients Diagnosed With Bipolar I Disorder: A 50-Week Open-Label, Flexible-Dose Trial.
Paediatr Drugs;
18(5): 367-78, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27461426
8.
Asenapine: Efficacy and safety of 5 and 10mg bid in a 3-week, randomized, double-blind, placebo-controlled trial in adults with a manic or mixed episode associated with bipolar I disorder.
J Affect Disord;
190: 103-110, 2016 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26496015
9.
Asenapine for the Acute Treatment of Pediatric Manic or Mixed Episode of Bipolar I Disorder.
J Am Acad Child Adolesc Psychiatry;
54(12): 1032-41, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26598478
10.
Safety and Efficacy from an 8 Week Double-Blind Trial and a 26 Week Open-Label Extension of Asenapine in Adolescents with Schizophrenia.
J Child Adolesc Psychopharmacol;
25(5): 384-96, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26091193
11.
Weight change and metabolic effects of asenapine in patients with schizophrenia and bipolar disorder.
J Clin Psychiatry;
75(3): 238-45, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24499969
12.
Naltrexone/Bupropion combination therapy in overweight or obese patients with major depressive disorder: results of a pilot study.
Prim Care Companion CNS Disord;
15(3)2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24171147
13.
Effect of olanzapine on cognition during treatment of behavioral and psychiatric symptoms in patients with dementia: a post-hoc analysis.
Int J Geriatr Psychiatry;
23(4): 364-9, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-17708584
14.
Zonisamide prevents olanzapine-associated hyperphagia, weight gain, and elevated blood glucose in rats.
Neuropsychopharmacology;
33(12): 2922-33, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18322467
15.
The cost of treating anxiety: the medical and demographic correlates that impact total medical costs.
Depress Anxiety;
21(4): 178-84, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-16075454
16.
Medical and productivity costs of anxiety disorders: case control study.
Depress Anxiety;
19(2): 112-20, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15022146
Resultados
1 -
16
de 16
1
Próxima >
>>